Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2013 3
2014 1
2015 2
2016 2
2018 3
2021 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee.
Borre ED, Ahonkhai AA, Chi KK, Osman A, Thayer K, Person AK, Weddle A, Flanagan CF, Pettit AC, Closs D, Cotton M, Agwu AL, Cespedes MS, Ciaranello AL, Gonsalves G, Hyle EP, Paltiel AD, Freedberg KA, Neilan AM. Borre ED, et al. Among authors: cespedes ms. Clin Infect Dis. 2024 Dec 17;79(6):1458-1467. doi: 10.1093/cid/ciae243. Clin Infect Dis. 2024. PMID: 38913762 Free PMC article.
Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.
Cespedes MS, Das M, Yager J, Prins M, Krznaric I, de Jong J, Xiao D, Shao Y, Wong P, Kintu A, Carter C, Hoornenborg E, Ruane P, Phoenix J, Younis I, Halperin J. Cespedes MS, et al. Transgend Health. 2024 Jan 31;9(1):46-52. doi: 10.1089/trgh.2022.0048. eCollection 2024 Feb. Transgend Health. 2024. PMID: 38312459 Free PMC article.
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
Wilkin TJ, Chen H, Cespedes MS, Leon-Cruz JT, Godfrey C, Chiao EY, Bastow B, Webster-Cyriaque J, Feng Q, Dragavon J, Coombs RW, Presti RM, Saah A, Cranston RD. Wilkin TJ, et al. Among authors: cespedes ms. Clin Infect Dis. 2018 Oct 15;67(9):1339-1346. doi: 10.1093/cid/ciy274. Clin Infect Dis. 2018. PMID: 29659751 Free PMC article. Clinical Trial.
High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298.
Cranston RD, Cespedes MS, Paczuski P, Yang M, Coombs RW, Dragavon J, Saah A, Godfrey C, Webster-Cyriaque JY, Chiao EY, Bastow B, Wilkin T; ACTG 5298 Study Team. Cranston RD, et al. Among authors: cespedes ms. Sex Transm Dis. 2018 Apr;45(4):266-271. doi: 10.1097/OLQ.0000000000000745. Sex Transm Dis. 2018. PMID: 29528986 Free PMC article. Clinical Trial.
15 results